{
    "eid": "2-s2.0-85146761744",
    "title": "Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "cancer marker identification",
        "triple negative breast cancer",
        "tyrosine kinase"
    ],
    "authors": [
        "Praopim Limsakul",
        "Pongsakorn Choochuen",
        "Gorn Charupanit",
        "Krit Charupanit"
    ],
    "citedby-count": 0,
    "ref-count": 78,
    "ref-list": [
        "Breast cancer",
        "Triple-negative breast cancer: Is there a treatment on the horizon?",
        "Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes",
        "Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies",
        "Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection",
        "Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerIdentification of Four Unique Subtypes of TNBCs",
        "Immune checkpoint inhibitors in triple negative breast cancer treatment: Promising future prospects",
        "Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer",
        "Receptor tyrosine kinase-targeted cancer therapy",
        "Tyrosine kinases as targets for cancer therapy",
        "The changing paradigm for the treatment of HER2-positive breast cancer",
        "Tyrosine kinase inhibitors in breast cancer",
        "Triple negative tumours: A critical review",
        "Prognostic markers in triple-negative breast cancer",
        "Predictive biomarker profiling of >6000 breast cancer patients shows heterogeneity in TNBC, with treatment implications",
        "Functional Proteomic Profiling of Triple-Negative Breast Cancer",
        "Protein tyrosine kinase 7 regulates EGFR/Akt signaling pathway and correlates with malignant progression in triple-negative breast cancer",
        "The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFR\u03b1, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer",
        "A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers",
        "Src: A potential target for the treatment of triple-negative breast cancer",
        "2021 FDA approvals",
        "Breast cancer drug approvals by the US FDA from 1949 to 2018",
        "Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021",
        "US FDA drug approvals for breast cancer: A decade in review",
        "Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development",
        "A perspective on anti-EGFR therapies targeting triple-negative breast cancer",
        "The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells",
        "Comprehensive molecular portraits of human breast tumours",
        "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2",
        "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources",
        "KEA3: Improved kinase enrichment analysis via data integration",
        "KinMap: A web-based tool for interactive navigation through human kinome data",
        "Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy",
        "Integrative clinical genomics of metastatic cancer",
        "The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups",
        "The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity",
        "The protein kinase complement of the human genome",
        "Dual mechanisms of LYN kinase dysregulation drive aggressive behavior in breast cancer cells",
        "Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer CellsPhosphoproteomic Profiling of Breast Cancer",
        "Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence",
        "Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research",
        "Pathogenesis and potential therapeutic targets for triple-negative breast cancer",
        "Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers",
        "Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer",
        "Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells",
        "LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast CancerLYN: EMT Mediator and Dasatinib Target in Breast Cancer",
        "PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein",
        "Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer",
        "The role of Eph receptors in cancer and how to target them: Novel approaches in cancer treatment",
        "Effects of Txk-mediated activation of NF-\u03baB signaling pathway on neurological deficit and oxidative stress after ischemia-reperfusion in rats",
        "Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum",
        "Locally recurrent secretory carcinoma of the breast with NTRK3 gene fusion",
        "EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer",
        "Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy",
        "Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer",
        "Prognostic value of ERBB4 expression in patients with triple negative breast cancer",
        "The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein",
        "Biological subtypes of triple-negative breast cancer",
        "FGFR3 signaling and function in triple negative breast cancer",
        "The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51",
        "Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation",
        "TGF-\u03b2 stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer",
        "Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness",
        "Identification of personalized chemoresistance genes in subtypes of basal-like breast cancer based on functional differences using pathway analysis",
        "c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo",
        "Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/\u201ctriple-negative\u201d breast cancer cell lines growing in vitro",
        "c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment",
        "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer",
        "Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells",
        "The FGF/FGFR system in breast cancer: Oncogenic features and therapeutic perspectives",
        "Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models",
        "The journey of DDR1 and DDR2 kinase inhibitors as rising Stars in the fight against cancer",
        "LMTK3 confers chemo-resistance in breast cancer",
        "The structure-function relationship of oncogenic LMTK3",
        "Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system",
        "Insights into the regulation of protein abundance from proteomic and transcriptomic analyses",
        "The somatic mutation profiles of 2433 breast cancers refine their genomic and transcriptomic landscapes",
        "Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pattani",
            "@id": "106166360",
            "affilname": "Pattani Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106166360",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "NSRF",
        "National Science, Research and Innovation Fund",
        "Prince of Songkla University"
    ]
}